246960 — SCL Science Income Statement
0.000.00%
Last trade - 00:00- KR₩61bn
- KR₩78bn
- KR₩22bn
Annual income statement for SCL Science, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 507 | 370 | 1,322 | 4,737 | 22,011 |
| Cost of Revenue | |||||
| Gross Profit | 183 | 68.4 | 208 | 1,809 | 4,201 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 5,173 | 4,975 | 8,310 | 8,398 | 25,445 |
| Operating Profit | -4,665 | -4,605 | -6,988 | -3,661 | -3,435 |
| Total Net Non Operating Interest Income / Expense | |||||
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -5,013 | -5,984 | -5,023 | -3,729 | -4,771 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -5,040 | -5,972 | -5,026 | -3,730 | -4,120 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -5,029 | -5,972 | -5,026 | -3,730 | -3,934 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -5,029 | -5,972 | -5,026 | -3,730 | -3,934 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -245 | -283 | -122 | -129 | -121 |
| Dividends per Share |